Using Magnetic Resonance Relaxometry to Evaluate the Safety and Quality of Induced Pluripotent Stem Cell-derived Spinal Cord Progenitor Cells

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2024 Dec 5

PMID 39639398

Authors

Jerome Tan

Jiahui Chen

Daniel Roxby

Wai Hon Chooi

Tan Dai Nguyen

Shi Yan Ng

Jongyoon Han

Sing Yian Chew

Affiliations

Soon will be listed here.

Abstract

Background: The emergence of induced pluripotent stem cells (iPSCs) offers a promising approach for replacing damaged neurons and glial cells, particularly in spinal cord injuries (SCI). Despite its merits, iPSC differentiation into spinal cord progenitor cells (SCPCs) is variable, necessitating reliable assessment of differentiation and validation of cell quality and safety. Phenotyping is often performed via label-based methods including immunofluorescent staining or flow cytometry analysis. These approaches are often expensive, laborious, time-consuming, destructive, and severely limits their use in large scale cell therapy manufacturing settings. On the other hand, cellular biophysical properties have demonstrated a strong correlation to cell state, quality and functionality and can be measured with ingenious label-free technologies in a rapid and non-destructive manner.

Method: In this study, we report the use of Magnetic Resonance Relaxometry (MRR), a rapid and label-free method that indicates iron levels based on its readout (T). Briefly, we differentiated human iPSCs into SCPCs and compared key iPSC and SCPC cellular markers to their intracellular iron content (Fe) at different stages of the differentiation process.

Results: With MRR, we found that intracellular iron of iPSCs and SCPCs were distinctively different allowing us to accurately reflect varying levels of residual undifferentiated iPSCs (i.e., OCT4 cells) in any given population of SCPCs. MRR was also able to predict Day 10 SCPC OCT4 levels from Day 1 undifferentiated iPSC T values and identified poorly differentiated SCPCs with lower T, indicative of lower neural progenitor (SOX1) and stem cell (Nestin) marker expression levels. Lastly, MRR was able to provide predictive indications for the extent of differentiation to Day 28 spinal cord motor neurons (ISL-1/SMI-32) based on the T values of Day 10 SCPCs.

Conclusion: MRR measurements of iPSCs and SCPCs has clearly indicated its capabilities to identify and quantify key phenotypes of iPSCs and SCPCs for end-point validation of safety and quality parameters. Thus, our technology provides a rapid label-free method to determine critical quality attributes in iPSC-derived progenies and is ideally suited as a quality control tool in cell therapy manufacturing.

References

Lee H, Ko K, Kim H, Rosebud Aikins A, Kim C . Ferritin is associated with neural differentiation of bone marrow-derived mesenchymal stem cells under extremely low-frequency electromagnetic field. Cell Mol Biol (Noisy-le-grand). 2015; 61(7):55-9. View

Zeming K, Vernekar R, Chua M, Quek K, Sutton G, Kruger T . Label-Free Biophysical Markers from Whole Blood Microfluidic Immune Profiling Reveal Severe Immune Response Signatures. Small. 2021; 17(12):e2006123. DOI: 10.1002/smll.202006123. View

Petchakup C, Yang H, Gong L, He L, Tay H, Dalan R . Microfluidic Impedance-Deformability Cytometry for Label-Free Single Neutrophil Mechanophenotyping. Small. 2022; 18(18):e2104822. DOI: 10.1002/smll.202104822. View

Kao Y, Chen J, Kumari R, Ng A, Zintiridou A, Tatiparthy M . An iron rheostat controls hematopoietic stem cell fate. Cell Stem Cell. 2024; 31(3):378-397.e12. PMC: 10939794. DOI: 10.1016/j.stem.2024.01.011. View

Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W . The Role of Iron in Cancer Progression. Front Oncol. 2021; 11:778492. PMC: 8631356. DOI: 10.3389/fonc.2021.778492. View

Han L, He H, Yang Y, Meng Q, Ye F, Chen G . Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient. Stem Cells Dev. 2022; 31(5-6):97-101. DOI: 10.1089/scd.2021.0255. View

Cozzi A, Orellana D, Santambrogio P, Rubio A, Cancellieri C, Giannelli S . Stem Cell Modeling of Neuroferritinopathy Reveals Iron as a Determinant of Senescence and Ferroptosis during Neuronal Aging. Stem Cell Reports. 2019; 13(5):832-846. PMC: 6893074. DOI: 10.1016/j.stemcr.2019.09.002. View

Saleh R, Reza H . Short review on human umbilical cord lining epithelial cells and their potential clinical applications. Stem Cell Res Ther. 2017; 8(1):222. PMC: 5634865. DOI: 10.1186/s13287-017-0679-y. View

Stroncek D, Jin P, Ren J, Feng J, Castiello L, Civini S . Quality assessment of cellular therapies: the emerging role of molecular assays. Korean J Hematol. 2010; 45(1):14-22. PMC: 2983004. DOI: 10.5045/kjh.2010.45.1.14. View

10.

Suzuki H, Imajo Y, Funaba M, Nishida N, Sakamoto T, Sakai T . Current Concepts of Neural Stem/Progenitor Cell Therapy for Chronic Spinal Cord Injury. Front Cell Neurosci. 2022; 15:794692. PMC: 8850278. DOI: 10.3389/fncel.2021.794692. View

11.

Sugai K, Sumida M, Shofuda T, Yamaguchi R, Tamura T, Kohzuki T . First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol. Regen Ther. 2021; 18:321-333. PMC: 8427225. DOI: 10.1016/j.reth.2021.08.005. View

12.

Rohrer J, Joo M, Dartyge E, Sayers D, Fontaine A, Theil E . Stabilization of iron in a ferrous form by ferritin. A study using dispersive and conventional x-ray absorption spectroscopy. J Biol Chem. 1987; 262(28):13385-7. View

13.

Hirayama T, Nagasawa H . Chemical tools for detecting Fe ions. J Clin Biochem Nutr. 2017; 60(1):39-48. PMC: 5281535. DOI: 10.3164/jcbn.16-70. View

14.

Nakamura M, Okano H . Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res. 2012; 23(1):70-80. PMC: 3541652. DOI: 10.1038/cr.2012.171. View

15.

Kumamaru H, Kadoya K, Adler A, Takashima Y, Graham L, Coppola G . Generation and post-injury integration of human spinal cord neural stem cells. Nat Methods. 2018; 15(9):723-731. DOI: 10.1038/s41592-018-0074-3. View

16.

Hosseini S, Borys B, Karimi-Abdolrezaee S . Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances. Brain. 2023; 147(3):766-793. DOI: 10.1093/brain/awad392. View

17.

Qu Q, Li D, Louis K, Li X, Yang H, Sun Q . High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1. Nat Commun. 2014; 5:3449. DOI: 10.1038/ncomms4449. View

18.

Yasuda A, Tsuji O, Shibata S, Nori S, Takano M, Kobayashi Y . Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. Stem Cells. 2011; 29(12):1983-94. DOI: 10.1002/stem.767. View

19.

Killilea D, Wong S, Cahaya H, Atamna H, Ames B . Iron accumulation during cellular senescence. Ann N Y Acad Sci. 2004; 1019:365-7. DOI: 10.1196/annals.1297.063. View

20.

Ng S, Soh B, Rodriguez-Muela N, Hendrickson D, Price F, Rinn J . Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy. Cell Stem Cell. 2015; 17(5):569-84. PMC: 4839185. DOI: 10.1016/j.stem.2015.08.003. View